BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 19, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Novartis regulatory update

HHS said Novartis' cell culture influenza vaccine and adjuvant manufacturing facility in Holly Springs, N.C., is "pandemic ready." The facility, which was developed under a public-private partnership between HHS and Novartis' Novartis Vaccines and Diagnostics Inc. unit, is the first U.S. facility to use...

Read the full 200 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >